None

Tonix Pharmaceuticals: Revolutionizing Fibromyalgia Treatment

By Capital Traders Group:I recently wrote an article regarding Jazz Pharmaceutical (JAZZ) and its wonder drug, Xyrem. In short, Jazz dominates the market for narcolepsy treatment because Xyrem (sodium...

Tonix: A Small Biotech With The Potentially Huge Key To The Fibromyalgia Puzzle

By Jason Napodano: By Jason Napodano, CFA The purpose of this article is to introduce investors to Tonix Pharmaceuticals (TNXP.OB) and the company's very low dose sublingual formulation of cycloben...

Tonix Readies For Pivotal Fibromyalgia Program

By Jason Napodano: In February 2013, Tonix Pharmaceuticals (TNXP.OB) management met face-to-face with the U.S. FDA to discuss the design of the clinical program for TNX-102SL, the company's low-dose s...

Tonix financial update

Tonix Pharmaceuticals Completes Private Placement

NEW YORK, Dec. 5, 2012 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (OTCQB:TNXP) ("TONIX" or the "Company"), a specialty pharmaceutical company developing novel treatments for challenging...

Tonix Pharmaceuticals to Present at Fifth Annual LD Micro Conference

NEW YORK, Dec. 5, 2012 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (OTCQB:TNXP) ("TONIX" or the "Company"), a specialty pharmaceutical company developing novel treatments for challenging...

Tonix completes private placement of convertible debentures and warrants

Tonix Pharmaceuticals to Hold Annual Shareholders' Meeting on April 19, 2013

NEW YORK, NY--(Marketwired - April 11, 2013) - Tonix Pharmaceuticals Holding Corp. (OTCQB: TNXP) ("TONIX" or "the Company"), a specialty pharmaceutical company developing novel treatments for challen...

None